WO2006042858A3 - Complex comprising an antibiotic, a cyclodextrin and an interaction agent - Google Patents
Complex comprising an antibiotic, a cyclodextrin and an interaction agent Download PDFInfo
- Publication number
- WO2006042858A3 WO2006042858A3 PCT/EP2005/055389 EP2005055389W WO2006042858A3 WO 2006042858 A3 WO2006042858 A3 WO 2006042858A3 EP 2005055389 W EP2005055389 W EP 2005055389W WO 2006042858 A3 WO2006042858 A3 WO 2006042858A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- complex
- antibiotic
- cyclodextrin
- interaction agent
- advantageously
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0411200 | 2004-10-21 | ||
FR0411200A FR2876914A1 (en) | 2004-10-21 | 2004-10-21 | COMPLEX COMPRISING AN ANTIBIOTICS, A CYCLODEXTRIN AND AN INTERACTION AGENT |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006042858A2 WO2006042858A2 (en) | 2006-04-27 |
WO2006042858A3 true WO2006042858A3 (en) | 2006-07-20 |
Family
ID=34952492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/055389 WO2006042858A2 (en) | 2004-10-21 | 2005-10-19 | Complex comprising an antibiotic, a cyclodextrin and an interaction agent |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2876914A1 (en) |
WO (1) | WO2006042858A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2944280B1 (en) * | 2009-04-09 | 2012-08-03 | Galderma Res & Dev | PROCESS FOR THE PREPARATION OF MOLECULAR COMPLEXES BETWEEN ADAPALENE AND CYCLODEXTRINS |
US20120171184A1 (en) | 2010-12-31 | 2012-07-05 | Lajos Szente | Cellular hydration compositions |
EP4043037A1 (en) * | 2010-12-31 | 2022-08-17 | Eastpond Laboratories Limited | Cellular hydration compositions containing cyclodextrins |
ES2899756T3 (en) * | 2013-03-12 | 2022-03-14 | Primal Therapies Inc | Dental composition comprising chelator and base |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR920006911B1 (en) * | 1989-06-14 | 1992-08-22 | 신풍제약 주식회사 | Process for preparing stablized injectable piroxicam composition |
US5472954A (en) * | 1992-07-14 | 1995-12-05 | Cyclops H.F. | Cyclodextrin complexation |
WO2002032459A2 (en) * | 2000-10-17 | 2002-04-25 | Massachusetts Institute Of Technology | Method of increasing the efficacy of antibiotics by complexing with cyclodextrins |
FR2815540A1 (en) * | 2000-10-19 | 2002-04-26 | Separex Sa | A method and apparatus for making very fine particles containing a complex of an active principle and a cyclodextrin for e.g. pharmaceutical use by placing them in a solvent or solvents and contacting with a supercritical liquid |
WO2002089851A1 (en) * | 2001-03-06 | 2002-11-14 | Separex (Societe Anonyme) | Method for making host-client complexes |
FR2830760A1 (en) * | 2001-10-12 | 2003-04-18 | Pf Medicament | New process to complex active materials with a solid support in order to improve water solubility, using a supercritical fluid |
WO2003095498A1 (en) * | 2002-05-10 | 2003-11-20 | Yunqing Liu | Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process |
FR2854079A1 (en) * | 2003-04-25 | 2004-10-29 | Pf Medicament | Preparation of soluble molecular complexes, useful for delivering e.g. pharmaceuticals, by molecular diffusion of active agents into host molecules in presence of diffusion agent |
CN1562063A (en) * | 2004-03-17 | 2005-01-12 | 陕西省微生物研究所 | Medicinal preparation containing erythromycine ethylsuccinate |
WO2005097201A2 (en) * | 2004-04-01 | 2005-10-20 | Pierre Fabre Medicament | Inclusion complexes containing piroxicam, a cyclodextrin and arginine |
WO2005112637A1 (en) * | 2004-05-14 | 2005-12-01 | Decode Chemistry, Inc. | Formulations for non-parenteral use including hydrophobic cyclodextrins |
-
2004
- 2004-10-21 FR FR0411200A patent/FR2876914A1/en active Pending
-
2005
- 2005-10-19 WO PCT/EP2005/055389 patent/WO2006042858A2/en active Application Filing
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR920006911B1 (en) * | 1989-06-14 | 1992-08-22 | 신풍제약 주식회사 | Process for preparing stablized injectable piroxicam composition |
US5472954A (en) * | 1992-07-14 | 1995-12-05 | Cyclops H.F. | Cyclodextrin complexation |
WO2002032459A2 (en) * | 2000-10-17 | 2002-04-25 | Massachusetts Institute Of Technology | Method of increasing the efficacy of antibiotics by complexing with cyclodextrins |
FR2815540A1 (en) * | 2000-10-19 | 2002-04-26 | Separex Sa | A method and apparatus for making very fine particles containing a complex of an active principle and a cyclodextrin for e.g. pharmaceutical use by placing them in a solvent or solvents and contacting with a supercritical liquid |
WO2002089851A1 (en) * | 2001-03-06 | 2002-11-14 | Separex (Societe Anonyme) | Method for making host-client complexes |
FR2830760A1 (en) * | 2001-10-12 | 2003-04-18 | Pf Medicament | New process to complex active materials with a solid support in order to improve water solubility, using a supercritical fluid |
WO2003095498A1 (en) * | 2002-05-10 | 2003-11-20 | Yunqing Liu | Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process |
EP1514877A1 (en) * | 2002-05-10 | 2005-03-16 | Yunqing Liu | Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process |
FR2854079A1 (en) * | 2003-04-25 | 2004-10-29 | Pf Medicament | Preparation of soluble molecular complexes, useful for delivering e.g. pharmaceuticals, by molecular diffusion of active agents into host molecules in presence of diffusion agent |
CN1562063A (en) * | 2004-03-17 | 2005-01-12 | 陕西省微生物研究所 | Medicinal preparation containing erythromycine ethylsuccinate |
WO2005097201A2 (en) * | 2004-04-01 | 2005-10-20 | Pierre Fabre Medicament | Inclusion complexes containing piroxicam, a cyclodextrin and arginine |
WO2005112637A1 (en) * | 2004-05-14 | 2005-12-01 | Decode Chemistry, Inc. | Formulations for non-parenteral use including hydrophobic cyclodextrins |
Non-Patent Citations (6)
Title |
---|
CSERHATI, TIBOR ET AL: "Interaction of some antibiotics with hydroxypropyl-.beta.- cyclodextrin", JOURNAL OF INCLUSION PHENOMENA AND MOLECULAR RECOGNITION IN CHEMISTRY , 18(3), 265-74 CODEN: JIMCEN; ISSN: 0923-0750, 1994, XP008063855 * |
DATABASE WPI Section Ch Week 199312, Derwent World Patents Index; Class A96, AN 1993-098122, XP002375837 * |
DATABASE WPI Section Ch Week 200532, Derwent World Patents Index; Class B02, AN 2005-306970, XP002379930 * |
HEES VAN T ET AL: "APPLICATION OF SUPERCRITICAL CARBON DIOXIDE FOR THE PREPARATION OF A PIROXICAM-BETA-CYCLODEXTRIN INCLUSION COMPOUND", PHARMACOLOGICAL RESEARCH, ACADEMIC PRESS, LONDON, GB, vol. 16, no. 12, 1999, pages 1864 - 1870, XP008006992, ISSN: 1043-6618 * |
HEES VAN T ET AL: "APPLICATION OF SUPERCRITICAL CARBON DIOXIDE FOR THE PREPARATION OF DRUG-CYCLODEXTRIN INCLUSION COMPOUNDS", JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, KLUWER, DORDRECHT, NL, vol. 44, 2002, pages 271 - 274, XP008040794, ISSN: 1388-3127 * |
MURA P ET AL: "TERNARY SYSTEMS OF NAPROXEN WITH HYDROXYPROPYL-BETA-CYCLODEXTRIN AND AMINOACIDS", INTERNATIONAL JOURNAL OF PHARMACEUTICS, AMSTERDAM, NL, vol. 260, no. 2, 24 July 2003 (2003-07-24), pages 293 - 302, XP008062550, ISSN: 0378-5173 * |
Also Published As
Publication number | Publication date |
---|---|
FR2876914A1 (en) | 2006-04-28 |
WO2006042858A2 (en) | 2006-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1730163A4 (en) | Pharmaceuticals salts of 3-o-(3,3-dimethylsuccinyl) betulinic acid | |
WO2006032500A3 (en) | Immunogenic composition | |
WO2007113222A3 (en) | Immunogenic composition | |
WO2008136331A1 (en) | BRANCHED α-GLUCAN, α-GLUCOSYLTRANSFERASE PRODUCING THE SAME, METHOD FOR PRODUCING THE SAME AND USE THEREOF | |
WO2007041156A3 (en) | Antibiotic formulations, unit doses, kits, and methods | |
WO2006086250A3 (en) | A catheter lock solution comprising citrate and a paraben | |
WO2000009075A3 (en) | Chemically modified saponins and the use thereof as adjuvants | |
WO2007103719A3 (en) | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | |
WO2008030567A3 (en) | Dry powder compound formulations and uses thereof | |
MX2008002387A (en) | Oxidation method and compositions therefor. | |
WO2001092283A3 (en) | Cobalamin compounds useful as cardiovascular agents and as imaging agents | |
WO2005009356A3 (en) | Method for the preparation of controlled release formulations | |
WO2006130703A3 (en) | Modified release formulations of anti-irritability drugs | |
CL2013002144A1 (en) | Coating composition consisting essentially of a coating agent and a hydrolysis resistant silicon compound; its method of preparation; and organomodified silicon compound (div. sol 803-07) | |
NO20071944L (en) | Hydrolysis Stable Investment Agent Composition | |
WO2006042858A3 (en) | Complex comprising an antibiotic, a cyclodextrin and an interaction agent | |
WO2002056915A3 (en) | Complex of modafinil and cyclodextrin | |
WO2007081583A3 (en) | Anti-pneumococcal preparations and methods of use | |
WO2010035122A3 (en) | Complex consisting of polysaccharide and an hpb | |
WO2005007143A3 (en) | Use of makrolides and ketolides for the treatment of tuberculosis | |
WO2002042315A3 (en) | Macrolide solvates | |
WO2010077867A3 (en) | Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus | |
CA2163539A1 (en) | N-morpholino-n-nitrosaminoacetonitrile cyclodextrin inclusion complexes | |
WO2004073686A3 (en) | Menthol solutions of drugs | |
AU2003246844A1 (en) | Use of cyclodextrine as a pearly-lustring agent and pearly lustred compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 05801648 Country of ref document: EP Kind code of ref document: A2 |